Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.

Source:http://linkedlifedata.com/resource/pubmed/id/16585210

Cancer Res. 2006 Apr 1 66 7 3828-35

Download in:

View as

General Info

PMID
16585210